List of Exela Pharma Sciences Llc patents

Patent 10478453 was granted and assigned to Exela Pharma Sciences Llc on November, 2019 by the United States Patent and Trademark Office.

Patent 10905714 was granted and assigned to Exela Pharma Sciences Llc on February, 2021 by the United States Patent and Trademark Office.

Patent 10918662 was granted and assigned to Exela Pharma Sciences Llc on February, 2021 by the United States Patent and Trademark Office.

Patent 10933089 was granted and assigned to Exela Pharma Sciences Llc on March, 2021 by the United States Patent and Trademark Office.

Patent 10912795 was granted and assigned to Exela Pharma Sciences Llc on February, 2021 by the United States Patent and Trademark Office.

Patent 10905713 was granted and assigned to Exela Pharma Sciences Llc on February, 2021 by the United States Patent and Trademark Office.

Patent 10583155 was granted and assigned to Exela Pharma Sciences Llc on March, 2020 by the United States Patent and Trademark Office.

Patent 11510942 was granted and assigned to Exela Pharma Sciences Llc on November, 2022 by the United States Patent and Trademark Office.

Patent 11648262 was granted and assigned to Exela Pharma Sciences Llc on May, 2023 by the United States Patent and Trademark Office.

Patent 11642370 was granted and assigned to Exela Pharma Sciences Llc on May, 2023 by the United States Patent and Trademark Office.

Patent 11510941 was granted and assigned to Exela Pharma Sciences Llc on November, 2022 by the United States Patent and Trademark Office.

Patent 10653719 was granted and assigned to Exela Pharma Sciences Llc on May, 2020 by the United States Patent and Trademark Office.

Patent 11969439 was granted and assigned to Exela Pharma Sciences Llc on April, 2024 by the United States Patent and Trademark Office.